Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
Saiman
Lisa
L
Siegel
Jane
J
D000421:Alcaligenes; D016956:Burkholderia cepacia; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D003470:Culture Media; D003550:Cystic Fibrosis / Q000382:microbiology / Q000628:therapy*; D004866:Equipment Contamination / Q000517:prevention & control; D016041:Heart-Lung Transplantation; D006801:Humans; D017053:Infection Control / Q000592:standards*; D016040:Lung Transplantation; D008826:Microbial Sensitivity Tests; D008828:Microbiological Techniques; D017720:Molecular Epidemiology; D009170:Nontuberculous Mycobacteria; D009975:Orthomyxoviridae; D010356:Patient Isolation / Q000523:psychology; D017410:Practice Guidelines as Topic; D011550:Pseudomonas aeruginosa; D012136:Respiratory Syncytial Viruses; D012138:Respiratory Therapy / Q000295:instrumentation; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D013211:Staphylococcus aureus; D020615:Stenotrophomonas maltophilia
D003470:Culture Media